Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis.
Gkretsi V, Stylianopoulos T. · 2018
Read Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis. by Gkretsi V, Stylianopoulos T. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5945811.txt.
Introduction
Gkretsi and Stylianopoulos review how cell adhesion and matrix stiffness drive cancer invasion and metastasis. Their review appeared in Frontiers in Oncology. The extracellular matrix links to the cell through integrins. Those links reach the actin cytoskeleton and many signalling pathways. Cues from adhesion proteins help set a cell's invasive potential. Many such proteins are proposed targets against metastasis.
Tumours also stiffen as matrix builds up around them. That stiffening helps the tumour displace host tissue and grow. It also shapes cell and matrix interactions, the authors note. Stiff surroundings can push cancer cells to invade nearby tissue. The review ties these mechanical and adhesive cues together.
Catalog record
| CREATOR | Gkretsi V, Stylianopoulos T. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis By Vasiliki Gkretsi, Triantafyllos Stylianopoulos Published in: Frontiers in Oncology DOI: 10.3389/fonc.2018.00145 ABSTRACT Metastasis is a multistep process in which tumor extracellular matrix (ECM) and cancer cell cytoskeleton interactions are pivotal. ECM is connected, through integrins, to the cell’s adhesome at cell–ECM adhesion sites and through them to the actin cytoskeleton and various downstream signaling pathways that enable the cell to respond to external stimuli in a coordinated manner. Cues from cell-adhesion proteins are fundamental for defining the invasive potential of cancer cells, and many of these proteins have been proposed as potent targets for inhibiting cancer cell invasion and thus, metastasis. In addition, ECM accumulation is quite frequent within the tumor microenvironment leading in many cases to an intense fibrotic response, known as desmoplasia, and tumor stiffening. Stiffening is not only required for the tumor to be able to displace the host tissue and grow in size but also contributes to cell–ECM interactions and can promote cancer cell invasion to surrounding tissues. Here, we review the role of cell adhesion and matrix stiffness in cancer cell invasion and metastasis. Cancer cells undergo certain fundamental changes in terms of cell physiology to attain a malignant phenotype. They acquire self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, limitless replicative potential, evasion of apoptosis, sustained angiogenesis, and tissue invasion capacity that enables them to metastasize to distant sites of the body (1, 2). In fact, the latter is the unique “hallmark of cancer” that differentiates benign and malignant tumors and truly defines cancer (3). Metastasis is a complex process in which cancer cells spread from a primary site to other organs in the body. It consists of several steps and the involvement of the extracellular matrix (ECM), and the cytoskeleton is indisputable. During this process, malignant cells dissociate from the original tumor mass, reorganize their attachment to the ECM though alterations in cell–ECM adhesion dynamics, and start degrading surrounding ECM to eventually invade through adjacent tissues and/or intravasate into blood vessels and travel through the circulation to distant sites of the body (4). The establishment of a metastatic tumor at the new site is not random but rather seems to follow a pattern known as “metastatic tropism.” Cancer cells that have managed to survive in the circulation find a metastatic niche that, based on the “seed and soil” theory, is suitable for their growth (5–7). Hence, some cancer types metastasize according to circulation patterns or based on the anatomical proximity of neighboring organs or the host–organ microenvironment. For instance, prostate cancer shows a preference toward the bone, pancreatic cancer forms metastases to the lung and liver, and breast cancer metastasizes to the bone, liver, lung, and the brain (6–8). Notably, biophysical and biochemical cues from the tumor ECM affect each one of the “hallmarks of cancer” (9) and control cell–cell and cell–ECM adhesions, which in turn determine cancer cell invasion and metastasis (7). Thus, integrins, ECM-related adhesion proteins and cell–cell adhesion proteins play a vital role in regulating the various stages of metastasis and defining the aggressiveness of cancer cells (10). CELL–CELL AND CELL–ECM ADHESION PROTEINS IN CANCER CELL METASTASIS Cancer cells are able to invade the surrounding ECM in the form of single cells or as collective groups of cells moving together, depending on whether cell–cell adhesion proteins, such as E-cadherin, are completely or partially lost in the original tumor, respectively (11). Although integrin-independent migration has also been described (12), both modes of invasion are considered to be heavily dependent on integrin-mediated adhesion to the ECM, whereas collective invasion also requires dynamic cell–cell adhesions so that loosening of cell junctions becomes sufficient for invasion. Thus, E-cadherin expression or its localization in cell–cell junctions is often lost in advanced cancers and has been linked to higher incidence of metastasis (11). However, the actual outcome in terms of invasion is ultimately dependent upon the balance between E-cadherin-mediated adhesions and integrin cell–ECM adhesions (11). Integrins connect the ECM with the interior of the cell transmitting extracellular signals through the assembly of multiple protein complexes that act as adaptor proteins and also bear strong attachments to actin cytoskeleton (10). There are more than 180 cell–ECM proteins forming networks of protein–protein interactions at cell–ECM adhesion sites, which altogether comprise what is known as cell’s adhesome (13). Critical determinants in cell–ECM adhesions that also link the ECM directly or indirectly with the actin cytoskeleton include talin, paxillin, kindlins, vinculin, integrin-linked kinase (ILK), parvins [parvin alpha (PARVA), parvin beta, and parvin gamma], particularly interesting new cysteine–histidine rich protein (PINCH)-1, Ras suppressor-1 (RSU-1), vasodilator-stimulated phosphoprotein (VASP) and its interactor Migfilin (14), and α-actinin (15–17). Upon integrin, activation protein tyrosine kinases Src and focal adhesion kinase (FAK) are also activated promoting further cytoskeletal changes as well as activation of downstream signaling pathways vital for cell adhesion, proliferation, survival, migration, and invasion (Figure 1) (18). Small Rho GTPases, Rho, Rac, and Cdc42, as well as Rho-associated protein kinase (ROCK) are such downstream effectors known to coordinate cytoskeletal reorganization and cell migration. Interestingly, most of these components of the cell–ECM adhesions have been found to be significantly deregulated in most cancer types with their expression being associated with higher metastatic potential or lower survival rates (19–26). Moreover, increased levels of RhoA, RhoB, RhoC, Rac1, Cdc42, and ROCK, have been found in late-stage tumors and metastases with prognostic relevance in breast cancer (27, 28). This suggests a strong involvement of cell–ECM adhesion molecules in cancer cell metastasis, although the exact molecular mechanisms involved can be different depending on cell type, tumor location, or grade. In fact, research has shown that cancer cells can have different modes of invasion, and thus a different molecular mechanism activated every time (29, 30). For instance, Rho signaling through ROCK promotes a rounded bleb-associated mode of motility, whereas elongated cell motility is associated with Rac-dependent F-actin-rich protrusions and does not require Rho or ROCK (30). [Figure: Schematic representation of critical protein–protein interactions at cell–extracellular matrix (ECM) adhesion sites in cancer cells grown in low (left) and high (right) stiffness conditions. Several important protein complexes are formed at the cell–ECM sites that are vital for normal cell function. More specifically, integrin-linked kinase (ILK) binds to the cytoplasmic domain of integrins and also interacts with particularly interesting new cysteine–histidine rich protein (PINCH)-1 and parvin alpha (PARVA) forming a stable ternary complex at cell–ECM adhesions known as PIP (PINCH–ILK–PARVA) or IPP (ILK–PINCH–PARVA) complex (31). PARVA, in turn, binds directly to actin connecting the complex to the cytoskeleton of the cell. ILK has also been shown to interact with Kindlin-2 (also known as mitogen-inducible gene-2 or Mig-2) which again forms a protein complex with Migfilin and filamin A (FLNA) (32), an actin-crosslinking protein. Interestingly, Migfilin has been shown to interact with vasodilator-stimulated phosphoprotein (VASP) (14), regulating cell migration. Equally important is the interaction of integrins with talin (33) and paxillin, which in turn binds to focal adhesion kinase (FAK) (34) while FAK binds to Src (35), which has been also shown to interact with Migfilin regulating cell–ECM mediated survival (36). Note that all cell–ECM adhesion proteins have direct or indirect connection to the actin cytoskeleton, while they activate downstream effectors such